HTG2014-Section-Header-publications

2018

Fibroblast growth factor receptor 3 (FGFR3), peroxisome proliferator-activated receptor gamma (PPARg), and outcomes with nivolumab (nivo) in metastatic urothelial cancer (UC).

Galsky, M. et al. Fibroblast growth factor receptor 3 (FGFR3), peroxisome proliferator-activated receptor gamma (PPARg), and outcomes with nivolumab (nivo) in metastatic urothelial cancer (UC). Poster session presented at: Genitourniary Cancers Symposium; 2018 Feb 9; San Francisco, CA. J Clin Oncol 36, 2018 (suppl 6S; abstr 511).

View External Link

2017

Next-Generation Sequencing (NGS) of Two Independent Cohorts Identifies Eleven Circulating miRNAs for Diagnosis of Nash and Fibrosis

Francque, S. et. al, Next-Generation Sequencing (NGS) of Two Independent Cohorts Identifies Eleven Circulating miRNAs for Diagnosis of Nash and Fibrosis. Poster session presented at: The International Liver Congress (ILC), 2017 Apr; Amsterdam

Download pdf 934KB

Next-Generation Sequencing (NGS) of Two Independent Cohorts Identifies Eleven Circulating mirNAs for Diagnosis of Nash and Fibrosis

Francque S., et al. Next-Generation Sequencing (NGS) of Two Independent Cohorts Identifies Eleven Circulating mirNAs for Diagnosis of Nash and Fibrosis. Poster session presented at: The International Liver Congress (ILC), 2017 Apr; Amsterdam 

Download pdf 934KB

Page last updated September 16, 2021